Trials
CTD Holdings Clinical Trial
CTD Holding’s Trappsol Cyclodextrin trial is currently enrolling in two trial sites: Oakland, US and Manchester, UK. The Phase 1 trial in the US requires patients to be 18+ and is looking to recruit approximately 12 patients for a research study lasting up to 20 weeks. The Phase 1/2 trial in the UK is also looking…
Read More